SFX by Ex Libris Inc.

Title:	SMN regulates axonal local translation via miR-183/mTOR pathway
Source:	Human Molecular Genetics [0964-6906] Kye, M J yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Song, L. "Resveratrol Ameliorates Motor Neuron Degeneration and Improves Survival in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis." BioMed Research International 2014 (2014): 483501-483501.
description	2.	Hsu, S. "Survival of motor neuron protein downregulates miR-9 expression in patients with spinal muscular atrophy." The Kaohsiung journal of medical sciences 30.5 (2014): 229-234.
description	3.	Guay, C. "Diabetes mellitus, a microRNA-related disease?" Translational Research 157.4 (2011): 253-264.
description	4.	Goldsmith, C. "Optical imaging of neuronal activity and visualization of fine neural structures in non-desheathed nervous systems." PLoS ONE 9.7 (2014).
description	5.	Haramati, S. "miRNA malfunction causes spinal motor neuron disease." Proceedings of the National Academy of Sciences of the United States of America 107.29 (2010): 13111-13116.
description	6.	Kolfschoten, I G M G. "Role and therapeutic potential of microRNAs in diabetes." Diabetes, obesity & metabolism 11 Suppl 4.4 (2009): 118-29.
description	7.	Lau, P. "Dysregulated microRNAs in Neurodegenerative Disorders." Seminars in cell & developmental biology 21.7 (2010): 768-773.
description	8.	El Ouaamari, A. "miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells." Diabetes 57.10 (2008): 2708-2717.
description	9.	Stoffel, M. "microRNAs and the regulation of glucose and lipid metabolism." Diabetes, obesity & metabolism 9.s2 (2007): 67-73.
description	10.	Connolly, V. "Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas." Journal of epidemiology and community health 54.3 (2000): 173-7.
description	11.	Evans, J M M. "Socio-economic status, obesity and prevalence of Type 1 and Type 2 diabetes mellitus." Diabetic medicine 17.6 (2000): 478-80.
description	12.	Kharebava, G. "Requirement of 3-Phosphoinositide-Dependent Protein Kinase-1 for BDNF-Mediated Neuronal Survival." The journal of neuroscience 28.44 (2008): 11409-11420.
description	13.	Marc, G. "Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice." BioMed Research International 2013 (2013): 845345-845345.
description	14.	Dehwah, Mustafa Abdo Saif A. "MicroRNAs and Type 2 Diabetes/Obesity." Journal of Genetics and Genomics 39.1 (2012): 11-18.
description	15.	Sarkar, A. S. H. "Expression of microRNAs: potential molecular link between obesity, diabetes and cancer." Obesity reviews 12.12 (2011): 1050-1062.
description	16.	Tang, X. "Identification of glucose-regulated miRNAs from pancreatic beta cells reveals a role for miR-30d in insulin transcription." RNA 15.2 (2009): 287-293.
description	17.	von, Malin M. "Kinesin Light Chain 1 Gene Haplotypes in Three Conformational Diseases." NeuroMolecular Medicine 12.3 (2009): 229-36.
description	18.	Song, H. "MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1." Biochemical and biophysical research communications 388.2 (2009): 400-5.
description	19.	Narayan, P. "Pharmacology of epigenetics in brain disorders." British Journal of Pharmacology 159.2 (2009): 285-303.
description	20.	Tsai, L. "MicroRNAs in common diseases and potential therapeutic applications." Clinical and experimental pharmacology & physiology 37.1 (2010): 102-107.